We hypothesize that changes in DNA modifications of methylation of 5-methyl cytosine (5mC) and 5-hydroxymethylcytosine (5hmC) alter SPRY4 expression in CRC patients. This evidence concerns the gene SPRY4 and colorectal carcinoma.